系统免疫炎症指数与泌尿系恶性肿瘤预后关系的研究进展  

Research Progress on the Relationship between Systemic Immune Inflammation Index and Prognosis of Malignant Tumors in the Urinary System

作　　者：崔刘龙 陈国俊[2] 

机构地区：[1]青海大学研究生院,青海 西宁 [2]青海大学附属医院泌尿外科,青海 西宁

出　　处：《临床医学进展》2023年第8期13622-13629,共8页Advances in Clinical Medicine

摘　　要：全身炎症反应在促进肿瘤进展中起重要作用。系统免疫炎症指数(systemic immune inflammation index, SII)作为一种全身炎症反应的评价指标,被认为是结直肠癌、胃癌、乳腺癌等多种癌症预后的独立危险因素,可以预测多种恶性肿瘤患者的生存情况。近年来其与泌尿系恶性肿瘤预后间相关性的研究也得到广泛开展。本文对近年来SII与泌尿系恶性肿瘤预后之间关系的临床研究进行综述,旨在为临床判断泌尿系统恶性肿瘤患者的预后转归提供帮助。Systemic inflammatory response plays an important role in promoting tumor progression. The sys-temic immune inflammation index (SII), as an evaluation index of systemic inflammatory reaction, is considered as an independent risk factor for the prognosis of colorectal cancer, gastric cancer, breast cancer and other cancers, and can predict the survival of patients with various malignant tumors. In recent years, research on the correlation between it and the prognosis of malignant tu-mors in the urinary system has also been widely carried out. This article reviews the clinical studies on the relationship between SII and the prognosis of urinary system malignancies in recent years, in order to provide help for clinical judgment of the prognosis of patients with urinary system ma-lignancies.

关 键 词：系统免疫炎症指数 泌尿系统肿瘤 病理特征 预后 

分 类 号：R73[医药卫生—肿瘤]